Martingale Asset Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,315
Closed -$132K 809
2025
Q4
$132K Sell
16,315
-11,171
-41% -$122K ﹤0.01% 758
2025
Q3
$390K Sell
27,486
-1,570
-5% -$20.7K 0.01% 649
2025
Q2
$379K Buy
+29,056
New +$399K 0.01% 666
2024
Q4
Sell
-23,619
Closed -$317K 772
2024
Q3
$317K Sell
23,619
-25,734
-52% -$379K 0.01% 705
2024
Q2
$683K Sell
49,353
-28,945
-37% -$458K 0.01% 536
2024
Q1
$1.47M Buy
78,298
+8,584
+12% +$172K 0.03% 370
2023
Q4
$1.58M Sell
69,714
-1,656
-2% -$35.9K 0.03% 343
2023
Q3
$1.77M Buy
71,370
+18,147
+34% +$457K 0.04% 300
2023
Q2
$1.49M Buy
53,223
+14,370
+37% +$357K 0.03% 339
2023
Q1
$867K Buy
38,853
+9,519
+32% +$249K 0.02% 478
2022
Q4
$779K Buy
+29,334
New +$957K 0.02% 532

Other funds holding CCRN

Martingale Asset Management's CCRN Position: Q1 2026 in Review

Martingale Asset Management sold out of Cross Country Healthcare (CCRN) in Q1 2026, closing a stake of 16,315 shares — an estimated $132K sold.

Martingale Asset Management first reported a position in CCRN in Q4 2022 and held it in 11 quarters. The position peaked at $1.77M in Q3 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Martingale Asset Management reported no remaining Cross Country Healthcare position as of Q1 2026 after selling out during the quarter.
  • Martingale Asset Management sold 16,315 Cross Country Healthcare shares in Q1 2026, an estimated $132K.
  • Martingale Asset Management first reported a position in Cross Country Healthcare in Q4 2022 and held it in 11 quarters.
  • Martingale Asset Management's Cross Country Healthcare position peaked at $1.77M in Q3 2023.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.